SCHEMBL6408384

SCHEMBL6408384

Cc1c(Cl)cc(NC(=O)C(=O)Nc2cc(Cl)cc(Cl)c2O)c(O)c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 1/20 0.52
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
GPR35 Q9HC97 3/20 0.38
AKR1C4 P17516 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
PTGS1 P23219 1/20 0.35
TBXAS1 P24557 1/20 0.35
MAPK1 P28482 1/20 0.35
PTGS2 P35354 1/20 0.35
MAPK14 Q16539 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ERN1 O75460 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6416431 0.91 GPR35 (0.44) HSPA5ALDH1A1HSD17B10TSHRGPR35
SCHEMBL6410292 0.85 HSPA5 (0.62) HSPA5ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL9096561 0.80 GPR35 (0.39) HSPA5ALDH1A1HSD17B10GPR35MEN1
SCHEMBL7027625 0.79 ALDH1A1 (0.41) HSPA5ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL4358591 0.78 P2RY1 (0.49) ALDH1A1MEN1KMT2A
SCHEMBL6413565 0.77 HSPA5 (0.61) HSPA5ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL6407492 0.77 CXCR2 (0.47) HSPA5ALDH1A1PTGS2MEN1KMT2A
SCHEMBL9400489 0.75 HSPA5 (0.58) HSPA5ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL6407734 0.75 HSPA5 (0.51) HSPA5ALDH1A1HSD17B10CYP3A4TSHR
SCHEMBL6408135 0.75 KCNMA1 (0.55) HSPA5HSD17B10TSHRMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 CEREP SA (FR) 2005-06-09 US claimed
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 CEREP SA (FR) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 SERPINE1, SERPINC1, SERPINB1 HSPA5 4261/4885ALDH1A1 360/4885HSD17B10 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.